Roche Holding Ltd

Insider Reports History

Entity
Company
Location
Roche Holding, Ltd., Grenzacherstrasse 124, Basel, Switzerland
Signature
ROCHE FINANCE LTD, By: /s/ Peter Trybus, Authorized Signatory
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Roche Holding Ltd:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Entrada Therapeutics, Inc. 10%+ Owner Common Stock 2.81M $45M $15.99 Nov 2, 2021 Indirect
Jasper Therapeutics, Inc. 10%+ Owner Voting Common Stock 4.55M $2.95M $0.65 Jan 25, 2023 Indirect
Aligos Therapeutics, Inc. 10%+ Owner Common Stock, par value $0.0001 per share 11M Oct 25, 2023 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 Nov 2, 2021 Indirect
Entrada Therapeutics, Inc. 10%+ Owner Series B Preferred Stock 0 Nov 2, 2021 Indirect

Insider Reports Filed by Roche Holding Ltd

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALGS Aligos Therapeutics, Inc. Oct 25, 2023 0 $0 3 Nov 7, 2023 10%+ Owner
JSPR Jasper Therapeutics, Inc. Jan 25, 2023 1 -$142K 4 Jan 26, 2023 10%+ Owner
TRDA Entrada Therapeutics, Inc. Nov 2, 2021 4 $0 4 Nov 4, 2021 10%+ Owner
TRDA Entrada Therapeutics, Inc. Oct 28, 2021 0 $0 3 Oct 28, 2021 10%+ Owner
JSPR Jasper Therapeutics, Inc. Sep 24, 2021 0 $0 3 Oct 4, 2021 10%+ Owner